Diabetes Drug Delivery in Market

Diabetes drug delivery is a mature field which provides lots of opportunities to the pharmaceutical companies to market their products which cure the problem related to endcrinology. Various companies are manufacturing different drugs for diabetic patients and the health complication caused due to it .Some of the advanced products like insulin pumps, sensors, biomarkers and Innovation seem to be the key to success because it is quite mature and without novel functionality. Telemedicines and softwares related to Increased investments in research and development segment are expected to introduce competitive pharamaceutical products at cost effective prices in short time. This latest research on diabetes showas that the diabetes drug market segment would be filled with innovative products that would be able to offer better diabetes management which will protect from  swollen pancreas  to patients.

Related conference for Diabetes Drug Delivery in market :

International Conference on Aleternative Ayurvedic and Herbal Medicine for Diabetes June 6-8 2016, China, 15th Global Diabetes Summit and Medicare Expo Nov 14-16 2016, Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016 Dubai, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 12th  Diabetes Meeting and Therapeutics Expo September 29-October1 2016,Canada;86th Annual Meeting of the American Thyroid Association September 21-25, 2016, Colorado; Young Investigators in Lipid metabolisim meetings 10-11 May 2016, Germany, United States; 5th World Congress on Controversies to Consensus in obesity and diabetes 5-7 Nov 2016, Turkey; 16th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism  19-22 November 2015,Albania; 3rd International Conference on Nutrition and Growth March 17-19 2016, Austria, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

The global diabetes market is expected to reach $44.70 billion in 2015 with a compound annual growth rate (CAGR) of 7.5 per cent. The growth in the Asian market is estimated to be high fuelling the Rest-of-World market share to 15.9 per cent in 2015. Europe and Japan are expected to have a share of 31.3 and 9.5 per cent in 2015. In the United States about 24 million people are estimated to be affected with diabetes. Out of this 24 million approximately 23.0 per cent (5.7 million) still remain undiagnosed. About 1.6 million new cases were diagnosed in people aged 20 and over. In the United States, diabetes is the leading cause of blindness, kidney failure and amputations. People with diabetes have higher risk of death than those without diabetes.


  • New medications for treatment of diabetes
  • Insulin pumps
  • Glucose sensors (invasive and non-invasive)
  • Implantable pumps and sensors
  • New Insulin delivery systems: Inhaled, transderma, implanted devices
  • New Insulin analogues
  • Devices focused on diabetic preventions
  • Informatics in the service of medicine
  • Telemedicine software and other technologies
  • New technologies and drugs for treating obesity

Related Conference of Diabetes Drug Delivery in Market

Diabetes Drug Delivery in Market Conference Speakers